These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 32050243)

  • 1. Severe corneal melting after cataract surgery in patients prescribed topical postoperative NSAIDs and dexamethasone/neomycin combination therapy.
    Cabourne E; Lau N; Flanagan D; Nott J; Bloom J; Angunawela R
    J Cataract Refract Surg; 2020 Jan; 46(1):138-142. PubMed ID: 32050243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maxitrol-induced corneal melts after routine cataract surgery in rheumatology patients.
    Lockington D; Sharma R; Mantry S; Ramaesh K
    Clin Exp Ophthalmol; 2015 Mar; 43(2):188-9. PubMed ID: 24995710
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery.
    van Endt JJ; Veraart HG; Kramer R; Janssen AG; Sunder Raj P
    Eur J Ophthalmol; 1997; 7(2):144-8. PubMed ID: 9243217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.
    Flach AJ
    Trans Am Ophthalmol Soc; 2001; 99():205-10; discussion 210-2. PubMed ID: 11797308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic keratolysis from combined use of nonsteroid anti-inflammatory drugs and topical steroids following vitreoretinal surgery.
    Alvarez MT; Figueroa MS; Teus MA
    Eur J Ophthalmol; 2006; 16(4):582-7. PubMed ID: 16952098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
    Guidera AC; Luchs JI; Udell IJ
    Ophthalmology; 2001 May; 108(5):936-44. PubMed ID: 11320025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs.
    Congdon NG; Schein OD; von Kulajta P; Lubomski LH; Gilbert D; Katz J
    J Cataract Refract Surg; 2001 Apr; 27(4):622-31. PubMed ID: 11311634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
    Shulman DG; Sargent JB; Stewart RH; Mester U
    Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug.
    Asai T; Nakagami T; Mochizuki M; Hata N; Tsuchiya T; Hotta Y
    Cornea; 2006 Feb; 25(2):224-7. PubMed ID: 16371788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.
    Lin JC; Rapuano CJ; Laibson PR; Eagle RC; Cohen EJ
    Arch Ophthalmol; 2000 Aug; 118(8):1129-32. PubMed ID: 10922213
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical NSAIDS to control pain in clear corneal cataract extraction.
    Goguen ER; Roberts CW
    Insight; 2004; 29(3):10-1. PubMed ID: 15552197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Punctal stenosis in 6 dogs following the long-term use of topical neomycin-polymyxin B-dexamethasone.
    Quantz K; Stiles J
    Vet Ophthalmol; 2019 Mar; 22(2):196-200. PubMed ID: 30211477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corneal melting and topical nonsteroidal anti-inflammatory drug (NSAID). A case report].
    Montes-Mollón MA; Pérez-Rico C; Beckford-Töngren C; Castro M; Pareja-Esteban J; Romero-García A
    Arch Soc Esp Oftalmol; 2009 Jun; 84(6):311-3. PubMed ID: 19568992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery.
    Vijay Zawar S; Mahadik S
    Can J Ophthalmol; 2014 Aug; 49(4):392-4. PubMed ID: 25103659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment.
    Flach A
    Ophthalmology; 2000 Jul; 107(7):1224-6. PubMed ID: 10889089
    [No Abstract]   [Full Text] [Related]  

  • 16. Nepafenac-associated corneal melt.
    Wolf EJ; Kleiman LZ; Schrier A
    J Cataract Refract Surg; 2007 Nov; 33(11):1974-5. PubMed ID: 17964407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Flach AJ; Dolan BJ
    Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAID-induced corneal melt: Clinical importance, pathogenesis, and risk mitigation.
    Rigas B; Huang W; Honkanen R
    Surv Ophthalmol; 2020; 65(1):1-11. PubMed ID: 31306671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.
    Zhao X; Xia S; Wang E; Chen Y
    PLoS One; 2017; 12(3):e0173254. PubMed ID: 28253334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAXITROL SUSPENSION AND OINTMENT: CLINICAL EVALUATION OF TWO NEW ANTIBIOTIC-STEROID PREPARATIONS.
    MAXWELL E; AIJIAN KM
    Curr Ther Res Clin Exp; 1964 Feb; 6():130-3. PubMed ID: 14135297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.